AJOONIAjooni Biotech Limited Forensic Risk Analysis
Financial profile remains stable for now. Pressure has stabilized in governance. This indicates that forensic pressure is currently receding. No major change in risk trend.
Score WaterfallAbsolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.
Investment Risk Thesis
Current risk score has declined from 9 → 0 over 13 quarters.
- Cash Conversion Deficit
- Negative FCF Streak
- Operating cash flow
- Operating profit margins
Active Risk Objects (2)
"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."
"High capital expenditure and low OCF are draining cash. Debt levels may rise sharply."
Correlation AnalysisVisualizing the relationship between stock price movement and structural risk objects.
The structural architecture is currently robust. Capital resilience buffers in governance remain well-maintained against forensic benchmarks. Systematic scans of structural transparency and audit trails confirm the absence of material structural stress. The current structural trajectory supports a stable risk outlook.
Stage 4 — Declining
The company is in a defensive phase. Sentiment and fundamentals are deteriorating under persistent downward pressure, indicating elevated risk levels.
PEER COMPARISON
Ranked comparison against sector peers
Stable
Stable
Stable
Watch
* Peer comparison is based on risk signals, not valuation or returns.
Risk Profiles
Deterioration Timeline
Cash Conversion Deficit
Negative FCF Streak
Cash Conversion Deficit
Negative FCF Streak
Cash Conversion Deficit